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OBJECTIVE — To examine the diabetes risk association with femur length, standing height,
and height without femur length (HWFL) (HWFL  standing height  femur length).
RESEARCH DESIGN AND METHODS — We used data from three time periods of the
National Health and Nutrition Examination Survey (1999–2000, 2001–2002, and 2003–2004)
forthiscross-sectionalanalysisandconﬁnedtheeligiblesubjectsto6,188adultsaged20years
whohadfasted8handhadnomissingvaluesoffemurlengthorstandingheight.Theoutcome
measure was type 2 diabetes.
RESULTS — Multivariate logistic regression analyses indicated that the odds of type 2 diabe-
tes per 1-SD value increase in femur length, standing height, and HWFL were 0.73 (95% CI
0.61–0.86), 0.91 (0.75–1.10), and 1.09 (0.90–1.32) for men, respectively, and 0.82 (0.70–
0.97), 0.99 (0.82–1.21), and 1.11 (0.93–1.33) for women.
CONCLUSIONS — Our study supports the hypothesis that femur length may be the key
height component in diabetes risk association.
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A
number of studies have observed
that adult height is negatively asso-
ciatedwiththeriskofglucoseintol-
erance, type 2 diabetes, and gestational
diabetes mellitus (1–4). It has been sug-
gested that short stature, in particular,
adult short-leg length in relation to trunk
length, is an indicator of poor childhood
environmental conditions (intrauterine
and/or early childhood) (5). This is con-
sidered to have modiﬁed some metabolic
pathways and thus inﬂuenced the risk of
developing diabetes. Recently, osteocal-
cin,oneoftheveryfewosteoblast-speciﬁc
proteins, has been discovered to have an
endocrineregulationeffectonglucoseho-
meostasis(6).Itwasfoundthatmicelack-
ing osteocalcin displayed decreased
pancreatic -cell proliferation, glucose
intolerance, and insulin resistance. Be-
cause the femur bone is the longest and
the strongest of the human bones, it
would theoretically be the most active
bone with respect to modeling and re-
modeling. It is possible that the observed
negative association between adult height
and the risk of diabetes is mainly deter-
mined by the altered length of the femur
bone. People with a longer femur bone
may be more likely to have a higher level
ofosteocalcin;thelongerfemurbonemay
thereforeexplaintheirlowerriskofdevel-
oping diabetes.
Using the data from the National
HealthandNutritionExaminationSurvey
(NHANES), we examined the diabetes
risk association with three different
height components: standing height, fe-
murlength,andtheheightwithoutfemur
length (HWFL) (HWFL  standing
heightfemurlength).Wehypothesized
that femur length is the key height com-
ponent contributing to the negative rela-
tionship between adult height and the
risk of diabetes.
RESEARCH DESIGN AND
METHODS— The NHANESs (1999–
2000, 2001–2002, and 2003–2004) are
national representative cross-sectional
surveys conducted with a stratiﬁed multi-
stage probability design of the U.S. pop-
ulation.ThedetailsofNHANESregarding
design, sampling, and data-collecting
procedures have been previously pub-
lished elsewhere (7). A total of 15,332
people aged 20 to 85 years were involved
in the three NHANES time periods.
Amongthem,6,943peoplewereassigned
to a morning session for physical exami-
nations and laboratory tests at the mobile
examinationcenter.Afterexcludingthose
who fasted 8 h, had a missing standing
height or femur length measurement,
were identiﬁed as pregnant, or had diabe-
tes diagnosed before age 40 years and
were currently treated with insulin, we
included a total of 6,188 subjects (3,128
menand3,060women)inthisstudy.An-
thropometric measures followed the sur-
vey protocol (8). Standing height was
measured using a specially designed sta-
diometer. Femur length was measured as
the length between the proximal and dis-
talendsofthefemurwhilethesubjectwas
sitting straight on a specially designed
measurement box, with the right knee
bent at a 90° angle (8). Measurements
were taken to the nearest tenth of a centi-
meter for both standing height and femur
length.TheHWFLwascalculatedbysub-
tracting femur length from standing
height. Diabetes in this study was deﬁned
by the criteria of the American Diabetes
Association (9) as either diabetes diagno-
sis by a physician before the surveys or
overnight fasting (8 h) plasma glucose
levels 125 mg/dl. Fasting plasma glu-
cose was determined from overnight fast-
ingbloodsamplesandwasmeasuredbya
modiﬁed hexokinase enzymatic method.
Datasets were analyzed with Stata
(version 8.2; StataCorp, College Station,
TX), which accounted for the weighted
and clustered nature of the NHANES
sample. Multivariate logistic regression
modelswereusedtoassesstheassociation
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mur length, standing height, and HWFL)
as continuous variables and the preva-
lence of diabetes with adjustment for age,
race, current smoking status, annual fam-
ily income, and waist circumference. The
statistical signiﬁcance level was set at a
two-tailed type I error of 0.05.
RESULTS— Overall,theprevalenceof
type 2 diabetes among this sample popu-
lation was 8.9% (men 9.4% and women
8.4%). The adjusted odds ratios of diabe-
tesfordifferentheightcomponentsbysex
are shown in Fig. 1. The odds of diabetes
were 0.73 (95% CI 0.61–0.86), 0.91
(0.75–1.10), and 1.09 (0.90–1.32) for
every 1-SD increase in femur length,
standing height, and HWFL in men, re-
spectively, and 0.82 (0.70–0.97), 0.99
(0.82–1.21), and 1.11 (0.93–1.33) in
women. To minimize the possibility of
the inﬂuence of age-related osteoporosis,
additional analyses were also conducted
among adults aged 60 years. These
analyses yielded similar patterns of re-
sults. In this subgroup, after adjusting for
thepotentialconfoundingvariables,1-SD
higher values in femur length, standing
height, and HWFL were associated with
odds of diabetes of 0.66 (0.52–0.84),
0.78 (0.59–1.04), and 0.97 (0.72–1.32),
respectively, for men and 0.84 (0.66–
1.07),1.00(0.74–1.36),and1.10(0.84–
1.45) for women.
CONCLUSIONS — Results from this
study indicate that femur length may be
thekeycomponentinheightcontributing
tothenegativeassociationbetweenheight
and the prevalence of type 2 diabetes. It
has been suggested that short leg length
and low leg-to-height ratio in adults re-
ﬂect impaired growth during childhood
(10). Although every part of height is
likely to be inﬂuenced by genetic factors,
it has been observed that the early child-
hood environment, in particular infant
nutrition, is an important determinant of
leg length (10–12). The results from Lee
et al. (6) suggest that short leg length
might indicate less capacity for the syn-
thesis of osteocalcin in bones. It is possi-
ble that the observed correlation between
short femur length and diabetic risk
might be the outcome of intrauterine or
earlychildhoodmetabolicalterationsthat
affect femur length. However, the lack of
osteocalcin measurement from NHANES
precludes direct testing of the hypothesis
that osteocalcin mediates the association
of femur length and the risk of type 2
diabetes.
Our analysis concludes that femur
length could be the key component in
height contributing to the risk of diabetes
in adults, independently of other known
risk factors. However, the novel hypoth-
esis of this association, that the level of
osteocalcin produced by the femur bone
might be crucial in the development of
type 2 diabetes, needs further research.
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Figure 1—Adjusted odds ratios of diabetes for different height measurements in 1 SD by sex according to NHANES (1999–2000, 2001–2002,
2003–2004). Adjusted for age, race, current smoking status, family income, and waist circumference. A: Men. B: Women.
Femur length and type 2 diabetes risk prediction
740 DIABETES CARE, VOLUME 32, NUMBER 4, APRIL 2009